Ammonium Thiosulfate Fertilizer
The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More
Global Transdermal Drug Patches Market Outlook 2024
1 Transdermal Drug Patches Market Overview
1.1 Product Overview and Scope of Transdermal Drug Patches
1.2 Transdermal Drug Patches Segment by Type
1.2.1 Global Transdermal Drug Patches Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Methyl Salicylate-based Patch
1.2.3 Rivastigmine Transdermal Patch
1.2.4 Fentanyl Transdermal Patch
1.2.5 Lidocaine Patch
1.2.6 Diclofenac Patch
1.2.7 Nicotine Transdermal Patch
1.2.8 Others
1.3 Transdermal Drug Patches Segment by Application
1.3.1 Global Transdermal Drug Patches Sales Comparison by Application: (2021-2027)
1.3.2 Rx Channel
1.3.3 OTC Channel
1.4 Global Transdermal Drug Patches Market Size Estimates and Forecasts
1.4.1 Global Transdermal Drug Patches Revenue 2016-2027
1.4.2 Global Transdermal Drug Patches Sales 2016-2027
1.4.3 Transdermal Drug Patches Market Size by Region: 2016 Versus 2021 Versus 2027
2 Transdermal Drug Patches Market Competition by Manufacturers
2.1 Global Transdermal Drug Patches Sales Market Share by Manufacturers (2016-2021)
2.2 Global Transdermal Drug Patches Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Transdermal Drug Patches Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Transdermal Drug Patches Manufacturing Sites, Area Served, Product Type
2.5 Transdermal Drug Patches Market Competitive Situation and Trends
2.5.1 Transdermal Drug Patches Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Transdermal Drug Patches Players Market Share by Revenue
2.5.3 Global Transdermal Drug Patches Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Transdermal Drug Patches Retrospective Market Scenario by Region
3.1 Global Transdermal Drug Patches Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Transdermal Drug Patches Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Transdermal Drug Patches Market Facts & Figures by Country
3.3.1 North America Transdermal Drug Patches Sales by Country
3.3.2 North America Transdermal Drug Patches Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Transdermal Drug Patches Market Facts & Figures by Country
3.4.1 Europe Transdermal Drug Patches Sales by Country
3.4.2 Europe Transdermal Drug Patches Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Transdermal Drug Patches Market Facts & Figures by Region
3.5.1 Asia Pacific Transdermal Drug Patches Sales by Region
3.5.2 Asia Pacific Transdermal Drug Patches Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Transdermal Drug Patches Market Facts & Figures by Country
3.6.1 Latin America Transdermal Drug Patches Sales by Country
3.6.2 Latin America Transdermal Drug Patches Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Transdermal Drug Patches Market Facts & Figures by Country
3.7.1 Middle East and Africa Transdermal Drug Patches Sales by Country
3.7.2 Middle East and Africa Transdermal Drug Patches Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Transdermal Drug Patches Historic Market Analysis by Type
4.1 Global Transdermal Drug Patches Sales Market Share by Type (2016-2021)
4.2 Global Transdermal Drug Patches Revenue Market Share by Type (2016-2021)
4.3 Global Transdermal Drug Patches Price by Type (2016-2021)
5 Global Transdermal Drug Patches Historic Market Analysis by Application
5.1 Global Transdermal Drug Patches Sales Market Share by Application (2016-2021)
5.2 Global Transdermal Drug Patches Revenue Market Share by Application (2016-2021)
5.3 Global Transdermal Drug Patches Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Hisamitsu Pharmaceutical
6.1.1 Hisamitsu Pharmaceutical Corporation Information
6.1.2 Hisamitsu Pharmaceutical Description and Business Overview
6.1.3 Hisamitsu Pharmaceutical Transdermal Drug Patches Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Hisamitsu Pharmaceutical Transdermal Drug Patches Product Portfolio
6.1.5 Hisamitsu Pharmaceutical Recent Developments/Updates
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson Corporation Information
6.2.2 Johnson & Johnson Description and Business Overview
6.2.3 Johnson & Johnson Transdermal Drug Patches Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Johnson & Johnson Transdermal Drug Patches Product Portfolio
6.2.5 Johnson & Johnson Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Corporation Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis Transdermal Drug Patches Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Novartis Transdermal Drug Patches Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 UCB Pharma
6.4.1 UCB Pharma Corporation Information
6.4.2 UCB Pharma Description and Business Overview
6.4.3 UCB Pharma Transdermal Drug Patches Sales, Revenue and Gross Margin (2016-2021)
6.4.4 UCB Pharma Transdermal Drug Patches Product Portfolio
6.4.5 UCB Pharma Recent Developments/Updates
6.5 Mylan
6.5.1 Mylan Corporation Information
6.5.2 Mylan Description and Business Overview
6.5.3 Mylan Transdermal Drug Patches Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Mylan Transdermal Drug Patches Product Portfolio
6.5.5 Mylan Recent Developments/Updates
6.6 Teva Pharmaceutical
6.6.1 Teva Pharmaceutical Corporation Information
6.6.2 Teva Pharmaceutical Description and Business Overview
6.6.3 Teva Pharmaceutical Transdermal Drug Patches Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Teva Pharmaceutical Transdermal Drug Patches Product Portfolio
6.6.5 Teva Pharmaceutical Recent Developments/Updates
6.7 Nitto Denko
6.6.1 Nitto Denko Corporation Information
6.6.2 Nitto Denko Description and Business Overview
6.6.3 Nitto Denko Transdermal Drug Patches Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Nitto Denko Transdermal Drug Patches Product Portfolio
6.7.5 Nitto Denko Recent Developments/Updates
6.8 Grünenthal
6.8.1 Grünenthal Corporation Information
6.8.2 Grünenthal Description and Business Overview
6.8.3 Grünenthal Transdermal Drug Patches Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Grünenthal Transdermal Drug Patches Product Portfolio
6.8.5 Grünenthal Recent Developments/Updates
6.9 IBSA Group
6.9.1 IBSA Group Corporation Information
6.9.2 IBSA Group Description and Business Overview
6.9.3 IBSA Group Transdermal Drug Patches Sales, Revenue and Gross Margin (2016-2021)
6.9.4 IBSA Group Transdermal Drug Patches Product Portfolio
6.9.5 IBSA Group Recent Developments/Updates
6.10 GSK
6.10.1 GSK Corporation Information
6.10.2 GSK Description and Business Overview
6.10.3 GSK Transdermal Drug Patches Sales, Revenue and Gross Margin (2016-2021)
6.10.4 GSK Transdermal Drug Patches Product Portfolio
6.10.5 GSK Recent Developments/Updates
6.11 Luye Pharma Group
6.11.1 Luye Pharma Group Corporation Information
6.11.2 Luye Pharma Group Transdermal Drug Patches Description and Business Overview
6.11.3 Luye Pharma Group Transdermal Drug Patches Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Luye Pharma Group Transdermal Drug Patches Product Portfolio
6.11.5 Luye Pharma Group Recent Developments/Updates
6.12 Pfizer
6.12.1 Pfizer Corporation Information
6.12.2 Pfizer Transdermal Drug Patches Description and Business Overview
6.12.3 Pfizer Transdermal Drug Patches Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Pfizer Transdermal Drug Patches Product Portfolio
6.12.5 Pfizer Recent Developments/Updates
6.13 Chattem
6.13.1 Chattem Corporation Information
6.13.2 Chattem Transdermal Drug Patches Description and Business Overview
6.13.3 Chattem Transdermal Drug Patches Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Chattem Transdermal Drug Patches Product Portfolio
6.13.5 Chattem Recent Developments/Updates
6.14 Dr Reddy’s Laboratories
6.14.1 Dr Reddy’s Laboratories Corporation Information
6.14.2 Dr Reddy’s Laboratories Transdermal Drug Patches Description and Business Overview
6.14.3 Dr Reddy’s Laboratories Transdermal Drug Patches Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Dr Reddy’s Laboratories Transdermal Drug Patches Product Portfolio
6.14.5 Dr Reddy’s Laboratories Recent Developments/Updates
6.15 Bayer
6.15.1 Bayer Corporation Information
6.15.2 Bayer Transdermal Drug Patches Description and Business Overview
6.15.3 Bayer Transdermal Drug Patches Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Bayer Transdermal Drug Patches Product Portfolio
6.15.5 Bayer Recent Developments/Updates
6.16 Mundipharma
6.16.1 Mundipharma Corporation Information
6.16.2 Mundipharma Transdermal Drug Patches Description and Business Overview
6.16.3 Mundipharma Transdermal Drug Patches Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Mundipharma Transdermal Drug Patches Product Portfolio
6.16.5 Mundipharma Recent Developments/Updates
6.17 Endo International
6.17.1 Endo International Corporation Information
6.17.2 Endo International Transdermal Drug Patches Description and Business Overview
6.17.3 Endo International Transdermal Drug Patches Sales, Revenue and Gross Margin (2016-2021)
6.17.4 Endo International Transdermal Drug Patches Product Portfolio
6.17.5 Endo International Recent Developments/Updates
6.18 Beijing Tide Pharmaceutical
6.18.1 Beijing Tide Pharmaceutical Corporation Information
6.18.2 Beijing Tide Pharmaceutical Transdermal Drug Patches Description and Business Overview
6.18.3 Beijing Tide Pharmaceutical Transdermal Drug Patches Sales, Revenue and Gross Margin (2016-2021)
6.18.4 Beijing Tide Pharmaceutical Transdermal Drug Patches Product Portfolio
6.18.5 Beijing Tide Pharmaceutical Recent Developments/Updates
7 Transdermal Drug Patches Manufacturing Cost Analysis
7.1 Transdermal Drug Patches Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Transdermal Drug Patches
7.4 Transdermal Drug Patches Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Transdermal Drug Patches Distributors List
8.3 Transdermal Drug Patches Customers
9 Transdermal Drug Patches Market Dynamics
9.1 Transdermal Drug Patches Industry Trends
9.2 Transdermal Drug Patches Growth Drivers
9.3 Transdermal Drug Patches Market Challenges
9.4 Transdermal Drug Patches Market Restraints
10 Global Market Forecast
10.1 Transdermal Drug Patches Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Transdermal Drug Patches by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Transdermal Drug Patches by Type (2022-2027)
10.2 Transdermal Drug Patches Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Transdermal Drug Patches by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Transdermal Drug Patches by Application (2022-2027)
10.3 Transdermal Drug Patches Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Transdermal Drug Patches by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Transdermal Drug Patches by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Transdermal Drug Patches Sales (M Pcs) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Transdermal Drug Patches Sales (M Pcs) Comparison by Application (2021-2027)
Table 3. Global Transdermal Drug Patches Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Transdermal Drug Patches Covered in This Study
Table 5. Global Transdermal Drug Patches Sales (M Pcs) of Key Manufacturers (2016-2021)
Table 6. Global Transdermal Drug Patches Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Transdermal Drug Patches Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Transdermal Drug Patches Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Transdermal Drug Patches Average Price (US$/Pc) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Transdermal Drug Patches Manufacturing Sites and Area Served
Table 11. Manufacturers Transdermal Drug Patches Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Transdermal Drug Patches by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transdermal Drug Patches as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Transdermal Drug Patches Sales by Region (2016-2021) & (M Pcs)
Table 16. Global Transdermal Drug Patches Sales Market Share by Region (2016-2021)
Table 17. Global Transdermal Drug Patches Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Transdermal Drug Patches Sales by Country (2016-2021) & (M Pcs)
Table 19. North America Transdermal Drug Patches Sales Market Share by Country (2016-2021)
Table 20. North America Transdermal Drug Patches Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Transdermal Drug Patches Revenue Market Share by Country (2016-2021)
Table 22. Europe Transdermal Drug Patches Sales by Country (2016-2021) & (M Pcs)
Table 23. Europe Transdermal Drug Patches Sales Market Share by Country (2016-2021)
Table 24. Europe Transdermal Drug Patches Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Transdermal Drug Patches Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Transdermal Drug Patches Sales by Region (2016-2021) & (M Pcs)
Table 27. Asia Pacific Transdermal Drug Patches Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Transdermal Drug Patches Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Transdermal Drug Patches Revenue Market Share by Region (2016-2021)
Table 30. Latin America Transdermal Drug Patches Sales by Country (2016-2021) & (M Pcs)
Table 31. Latin America Transdermal Drug Patches Sales Market Share by Country (2016-2021)
Table 32. Latin America Transdermal Drug Patches Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Transdermal Drug Patches Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Transdermal Drug Patches Sales by Country (2016-2021) & (M Pcs)
Table 35. Middle East and Africa Transdermal Drug Patches Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Transdermal Drug Patches Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Transdermal Drug Patches Revenue Market Share by Country (2016-2021)
Table 38. Global Transdermal Drug Patches Sales (M Pcs) by Type (2016-2021)
Table 39. Global Transdermal Drug Patches Sales Market Share by Type (2016-2021)
Table 40. Global Transdermal Drug Patches Revenue (Million US$) by Type (2016-2021)
Table 41. Global Transdermal Drug Patches Revenue Share by Type (2016-2021)
Table 42. Global Transdermal Drug Patches Price (US$/Pc) by Type (2016-2021)
Table 43. Global Transdermal Drug Patches Sales (M Pcs) by Application (2016-2021)
Table 44. Global Transdermal Drug Patches Sales Market Share by Application (2016-2021)
Table 45. Global Transdermal Drug Patches Revenue (Million US$) by Application (2016-2021)
Table 46. Global Transdermal Drug Patches Revenue Share by Application (2016-2021)
Table 47. Global Transdermal Drug Patches Price (US$/Pc) by Application (2016-2021)
Table 48. Hisamitsu Pharmaceutical Corporation Information
Table 49. Hisamitsu Pharmaceutical Description and Business Overview
Table 50. Hisamitsu Pharmaceutical Transdermal Drug Patches Sales (M Pcs), Revenue (Million US$), Price (US$/Pc) and Gross Margin (2016-2021)
Table 51. Hisamitsu Pharmaceutical Transdermal Drug Patches Product
Table 52. Hisamitsu Pharmaceutical Recent Developments/Updates
Table 53. Johnson & Johnson Corporation Information
Table 54. Johnson & Johnson Description and Business Overview
Table 55. Johnson & Johnson Transdermal Drug Patches Sales (M Pcs), Revenue (Million US$), Price (US$/Pc) and Gross Margin (2016-2021)
Table 56. Johnson & Johnson Transdermal Drug Patches Product
Table 57. Johnson & Johnson Recent Developments/Updates
Table 58. Novartis Corporation Information
Table 59. Novartis Description and Business Overview
Table 60. Novartis Transdermal Drug Patches Sales (M Pcs), Revenue (Million US$), Price (US$/Pc) and Gross Margin (2016-2021)
Table 61. Novartis Transdermal Drug Patches Product
Table 62. Novartis Recent Developments/Updates
Table 63. UCB Pharma Corporation Information
Table 64. UCB Pharma Description and Business Overview
Table 65. UCB Pharma Transdermal Drug Patches Sales (M Pcs), Revenue (Million US$), Price (US$/Pc) and Gross Margin (2016-2021)
Table 66. UCB Pharma Transdermal Drug Patches Product
Table 67. UCB Pharma Recent Developments/Updates
Table 68. Mylan Corporation Information
Table 69. Mylan Description and Business Overview
Table 70. Mylan Transdermal Drug Patches Sales (M Pcs), Revenue (Million US$), Price (US$/Pc) and Gross Margin (2016-2021)
Table 71. Mylan Transdermal Drug Patches Product
Table 72. Mylan Recent Developments/Updates
Table 73. Teva Pharmaceutical Corporation Information
Table 74. Teva Pharmaceutical Description and Business Overview
Table 75. Teva Pharmaceutical Transdermal Drug Patches Sales (M Pcs), Revenue (Million US$), Price (US$/Pc) and Gross Margin (2016-2021)
Table 76. Teva Pharmaceutical Transdermal Drug Patches Product
Table 77. Teva Pharmaceutical Recent Developments/Updates
Table 78. Nitto Denko Corporation Information
Table 79. Nitto Denko Description and Business Overview
Table 80. Nitto Denko Transdermal Drug Patches Sales (M Pcs), Revenue (Million US$), Price (US$/Pc) and Gross Margin (2016-2021)
Table 81. Nitto Denko Transdermal Drug Patches Product
Table 82. Nitto Denko Recent Developments/Updates
Table 83. Grünenthal Corporation Information
Table 84. Grünenthal Description and Business Overview
Table 85. Grünenthal Transdermal Drug Patches Sales (M Pcs), Revenue (Million US$), Price (US$/Pc) and Gross Margin (2016-2021)
Table 86. Grünenthal Transdermal Drug Patches Product
Table 87. Grünenthal Recent Developments/Updates
Table 88. IBSA Group Corporation Information
Table 89. IBSA Group Description and Business Overview
Table 90. IBSA Group Transdermal Drug Patches Sales (M Pcs), Revenue (Million US$), Price (US$/Pc) and Gross Margin (2016-2021)
Table 91. IBSA Group Transdermal Drug Patches Product
Table 92. IBSA Group Recent Developments/Updates
Table 93. GSK Corporation Information
Table 94. GSK Description and Business Overview
Table 95. GSK Transdermal Drug Patches Sales (M Pcs), Revenue (Million US$), Price (US$/Pc) and Gross Margin (2016-2021)
Table 96. GSK Transdermal Drug Patches Product
Table 97. GSK Recent Developments/Updates
Table 98. Luye Pharma Group Corporation Information
Table 99. Luye Pharma Group Description and Business Overview
Table 100. Luye Pharma Group Transdermal Drug Patches Sales (M Pcs), Revenue (Million US$), Price (US$/Pc) and Gross Margin (2016-2021)
Table 101. Luye Pharma Group Transdermal Drug Patches Product
Table 102. Luye Pharma Group Recent Developments/Updates
Table 103. Pfizer Corporation Information
Table 104. Pfizer Description and Business Overview
Table 105. Pfizer Transdermal Drug Patches Sales (M Pcs), Revenue (Million US$), Price (US$/Pc) and Gross Margin (2016-2021)
Table 106. Pfizer Transdermal Drug Patches Product
Table 107. Pfizer Recent Developments/Updates
Table 108. Chattem Corporation Information
Table 109. Chattem Description and Business Overview
Table 110. Chattem Transdermal Drug Patches Sales (M Pcs), Revenue (Million US$), Price (US$/Pc) and Gross Margin (2016-2021)
Table 111. Chattem Transdermal Drug Patches Product
Table 112. Chattem Recent Developments/Updates
Table 113. Dr Reddy’s Laboratories Corporation Information
Table 114. Dr Reddy’s Laboratories Description and Business Overview
Table 115. Dr Reddy’s Laboratories Transdermal Drug Patches Sales (M Pcs), Revenue (Million US$), Price (US$/Pc) and Gross Margin (2016-2021)
Table 116. Dr Reddy’s Laboratories Transdermal Drug Patches Product
Table 117. Dr Reddy’s Laboratories Recent Developments/Updates
Table 118. Bayer Corporation Information
Table 119. Bayer Description and Business Overview
Table 120. Bayer Transdermal Drug Patches Sales (M Pcs), Revenue (Million US$), Price (US$/Pc) and Gross Margin (2016-2021)
Table 121. Bayer Transdermal Drug Patches Product
Table 122. Bayer Recent Developments/Updates
Table 123. Mundipharma Corporation Information
Table 124. Mundipharma Description and Business Overview
Table 125. Mundipharma Transdermal Drug Patches Sales (M Pcs), Revenue (Million US$), Price (US$/Pc) and Gross Margin (2016-2021)
Table 126. Mundipharma Transdermal Drug Patches Product
Table 127. Mundipharma Recent Developments/Updates
Table 128. Endo International Corporation Information
Table 129. Endo International Description and Business Overview
Table 130. Endo International Transdermal Drug Patches Sales (M Pcs), Revenue (Million US$), Price (US$/Pc) and Gross Margin (2016-2021)
Table 131. Endo International Transdermal Drug Patches Product
Table 132. Endo International Recent Developments/Updates
Table 133. Beijing Tide Pharmaceutical Corporation Information
Table 134. Beijing Tide Pharmaceutical Description and Business Overview
Table 135. Beijing Tide Pharmaceutical Transdermal Drug Patches Sales (M Pcs), Revenue (Million US$), Price (US$/Pc) and Gross Margin (2016-2021)
Table 136. Beijing Tide Pharmaceutical Transdermal Drug Patches Product
Table 137. Beijing Tide Pharmaceutical Recent Developments/Updates
Table 138. Production Base and Market Concentration Rate of Raw Material
Table 139. Key Suppliers of Raw Materials
Table 140. Transdermal Drug Patches Distributors List
Table 141. Transdermal Drug Patches Customers List
Table 142. Transdermal Drug Patches Market Trends
Table 143. Transdermal Drug Patches Growth Drivers
Table 144. Transdermal Drug Patches Market Challenges
Table 145. Transdermal Drug Patches Market Restraints
Table 146. Global Transdermal Drug Patches Sales Forecast by Type (2022-2027) & (M Pcs)
Table 147. Global Transdermal Drug Patches Sales Market Share Forecast by Type (2022-2027)
Table 148. Global Transdermal Drug Patches Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 149. Global Transdermal Drug Patches Revenue Market Share Forecast by Type (2022-2027)
Table 150. Global Transdermal Drug Patches Sales Forecast by Application (2022-2027) & (M Pcs)
Table 151. Global Transdermal Drug Patches Sales Market Share Forecast by Application (2022-2027)
Table 152. Global Transdermal Drug Patches Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 153. Global Transdermal Drug Patches Revenue Market Share Forecast by Application (2022-2027)
Table 154. Global Transdermal Drug Patches Sales Forecast by Region (2022-2027) & (M Pcs)
Table 155. Global Transdermal Drug Patches Sales Market Share Forecast by Region (2022-2027)
Table 156. Global Transdermal Drug Patches Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 157. Global Transdermal Drug Patches Revenue Market Share Forecast by Region (2022-2027)
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Transdermal Drug Patches
Figure 2. Global Transdermal Drug Patches Market Share by Type in 2020 & 2027
Figure 3. Methyl Salicylate-based Patch Product Picture
Figure 4. Rivastigmine Transdermal Patch Product Picture
Figure 5. Fentanyl Transdermal Patch Product Picture
Figure 6. Lidocaine Patch Product Picture
Figure 7. Diclofenac Patch Product Picture
Figure 8. Nicotine Transdermal Patch Product Picture
Figure 9. Others Product Picture
Figure 10. Global Transdermal Drug Patches Market Share by Application in 2020 & 2027
Figure 11. Rx Channel
Figure 12. OTC Channel
Figure 13. Global Transdermal Drug Patches Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Transdermal Drug Patches Market Size 2016-2027 (US$ Million)
Figure 15. Global Transdermal Drug Patches Sales 2016-2027 (M Pcs)
Figure 16. Global Transdermal Drug Patches Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 17. Transdermal Drug Patches Sales Share by Manufacturers in 2020
Figure 18. Global Transdermal Drug Patches Revenue Share by Manufacturers in 2020
Figure 19. The Global 5 and 10 Largest Transdermal Drug Patches Players: Market Share by Revenue in 2020
Figure 20. Transdermal Drug Patches Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 21. Global Transdermal Drug Patches Sales Market Share by Region (2016-2021)
Figure 22. Global Transdermal Drug Patches Sales Market Share by Region in 2020
Figure 23. Global Transdermal Drug Patches Revenue Market Share by Region (2016-2021)
Figure 24. Global Transdermal Drug Patches Revenue Market Share by Region in 2020
Figure 25. U.S. Transdermal Drug Patches Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Canada Transdermal Drug Patches Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Germany Transdermal Drug Patches Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. France Transdermal Drug Patches Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. U.K. Transdermal Drug Patches Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Italy Transdermal Drug Patches Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Russia Transdermal Drug Patches Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. China Transdermal Drug Patches Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Japan Transdermal Drug Patches Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. South Korea Transdermal Drug Patches Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. India Transdermal Drug Patches Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Australia Transdermal Drug Patches Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. China Taiwan Transdermal Drug Patches Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Indonesia Transdermal Drug Patches Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Thailand Transdermal Drug Patches Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Malaysia Transdermal Drug Patches Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Mexico Transdermal Drug Patches Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Brazil Transdermal Drug Patches Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Argentina Transdermal Drug Patches Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Turkey Transdermal Drug Patches Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Saudi Arabia Transdermal Drug Patches Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. UAE Transdermal Drug Patches Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Sales Market Share of Transdermal Drug Patches by Type (2016-2021)
Figure 48. Sales Market Share of Transdermal Drug Patches by Application (2016-2021)
Figure 49. Sales Market Share of Transdermal Drug Patches by Application in 2020
Figure 50. Revenue Share of Transdermal Drug Patches by Application (2016-2021)
Figure 51. Revenue Share of Transdermal Drug Patches by Application in 2020
Figure 52. Manufacturing Cost Structure of Transdermal Drug Patches
Figure 53. Manufacturing Process Analysis of Transdermal Drug Patches
Figure 54. Transdermal Drug Patches Industrial Chain Analysis
Figure 55. Channels of Distribution
Figure 56. Distributors Profiles
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Hisamitsu Pharmaceutical Johnson & Johnson Novartis UCB Pharma Mylan Teva Pharmaceutical Nitto Denko Grünenthal IBSA Group GSK Luye Pharma Group Pfizer Chattem Dr Reddy’s Laboratories Bayer Mundipharma Endo International Beijing Tide Pharmaceutical